Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Consulting agrmnt

Pathfinder Cell Therapy, Inc. (PFND) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/05/2016 EFFECT Form EFFECT - Notice of Effectiveness
03/30/2016 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
03/29/2016 8-K Form 8-K - Current report
03/29/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/29/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/29/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/29/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/29/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/29/2016 EFFECT Form EFFECT - Notice of Effectiveness
03/29/2016 EFFECT Form EFFECT - Notice of Effectiveness
03/16/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
03/16/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
11/13/2015 10-Q Quarterly Report for the period ended September 30, 2015
08/13/2015 10-Q Quarterly Report for the period ended June 30, 2015
05/15/2015 10-Q Quarterly Report for the period ended March 31, 2015
03/31/2015 10-K Annual Report for the period ended December 31, 2014
11/14/2014 10-Q Quarterly Report for the period ended September 30, 2014
08/14/2014 10-Q Quarterly Report for the period ended June 30, 2014
05/27/2014 10-K/A Annual Report for the period ended December 31, 2012 [amend]
05/15/2014 10-Q Quarterly Report for the period ended March 31, 2014
04/30/2014 10-K/A Annual Report for the period ended December 31, 2013 [amend]
03/31/2014 10-K Annual Report for the period ended December 31, 2013
03/31/2014 10-K/A Annual Report for the period ended December 31, 2012 [amend]
11/14/2013 10-Q Quarterly Report for the period ended September 30, 2013
10/24/2013 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister...
08/14/2013 10-Q Quarterly Report for the period ended June 30, 2013
07/29/2013 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister...
05/29/2013 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister...
05/15/2013 10-Q Quarterly Report for the period ended March 31, 2013
04/30/2013 10-K/A Annual Report for the period ended December 31, 2012 [amend]
04/29/2013 5 Breisgau Bio Ventures S.A. (10% Owner) has filed a Form 5 on Pathfinder Cell Therapy, Inc.
04/01/2013 10-K Annual Report for the period ended December 31, 2012
03/07/2013 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister...
03/06/2013 4 Gruber Joerg (Chairman of the Board) has filed a Form 4 on Pathfinder Cell Therapy, Inc.
Txns: Bought convertible notes @ $100000, valued at $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy